Allergy Therapeutics Plc (AGY) Ord GBP0.01
0.23p
(5.23%)
- Add to watchlist
- Create an alert
- This stock can be held in a
0.23p
(5.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
0.23p
(5.23%)
Deal for just £11.95 per trade in a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
4.30p
4.75p
6.05p
£215.68 million
4.30p
4.20p
1.20p
n/a
0.10p (2.38%) Previous:
0.10p
263,022
n/a
150,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/06/2023 | 30/06/2022 |
|---|---|---|
| Revenue (£m) | 60.95 | 72.77 |
| Profit before tax (£m) | (49.83) | (12.66) |
| Adjusted EPS (p): | (7.61) | (2.14) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Allergy Therapeutics starts dosing peanut allergy vaccine candidate
27 March 2023 15:16
-
Allergy Therapeutics confident in funding as results remain late
20 January 2023 12:33
-
Allergy Therapeutics pauses production at Freeman facility
4 October 2022 14:10
-
Progression of patient cohorts in PROTECT Trial
17 September 2024 07:00
-
Update on funding
27 August 2024 07:00
-
Trading update for the year ended 30 June 2024
22 July 2024 07:01
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.